Home
Target list
Statistics
Structure galleries
Target nomination
Technologies
Web tools
Databases
Participating investigators
Publications
|
NESG statistics
NESG (complete history)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
23,038 |
34,956 |
17,431 |
| Expression tested |
|
   |
21,584 |
31,831 |
16,239 |
| Expressed (E > 0) |
|
   |
16,374 |
22,108 |
12,846 |
| Expressed-Soluble (S > 0) |
|
   |
12,150 |
15,371 |
10,200 |
| Expressed-Soluble (ES >= 9) |
|
   |
9,705 |
12,094 |
8,241 |
| Fermented |
|
   |
7,056 |
8,958 |
6,229 |
| Purified (>= 0.5 mg yield) |
|
   |
4,656 |
5,567 |
4,076 |
| HSQC spectra recorded |
|
   |
2,493 |
3,189 |
2,233 |
| "Good" HSQC spectra |
|
   |
1,305 |
1,648 |
1,186 |
| Crystal hit |
|
   |
1,277 |
1,424 |
1,176 |
| X-Ray structures |
|
   |
529 |
532 |
520 | 568 |
| NMR structures |
|
   |
438 |
440 |
432 | 458 | 41 |
| Total structures |
|
   |
926 |
939 |
904 | 1,026 |
[activity table created 2012-02-04]
NESG (PSI-1)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
5,514 |
7,692 |
5,345 |
| Expression tested |
|
   |
4,684 |
5,971 |
4,562 |
| Expressed (E > 0) |
|
   |
3,315 |
3,601 |
3,259 |
| Expressed-Soluble (S > 0) |
|
   |
2,519 |
2,718 |
2,495 |
| Expressed-Soluble (ES >= 9) |
|
   |
2,019 |
2,144 |
2,004 |
| Fermented |
|
   |
2,404 |
3,067 |
2,367 |
| Purified (>= 0.5 mg yield) |
|
   |
1,096 |
1,130 |
1,093 |
| HSQC spectra recorded |
|
   |
794 |
1,099 |
793 |
| "Good" HSQC spectra |
|
   |
347 |
488 |
346 |
| Crystal hit |
|
   |
146 |
146 |
146 |
| X-Ray structures |
|
   |
105 |
105 |
105 | 108 |
| NMR structures |
|
   |
80 |
80 |
80 | 83 | 2 |
| Total structures |
|
   |
183 |
183 |
183 | 191 |
[activity table created 2012-02-04]
NESG (PSI-2)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
14,750 |
20,908 |
10,515 |
| Expression tested |
|
   |
14,460 |
20,273 |
10,302 |
| Expressed (E > 0) |
|
   |
10,899 |
14,391 |
8,204 |
| Expressed-Soluble (S > 0) |
|
   |
8,240 |
10,346 |
6,704 |
| Expressed-Soluble (ES >= 9) |
|
   |
6,540 |
8,101 |
5,379 |
| Fermented |
|
   |
4,217 |
5,004 |
3,602 |
| Purified (>= 0.5 mg yield) |
|
   |
3,213 |
3,771 |
2,751 |
| HSQC spectra recorded |
|
   |
1,439 |
1,697 |
1,239 |
| "Good" HSQC spectra |
|
   |
811 |
955 |
714 |
| Crystal hit |
|
   |
1,033 |
1,147 |
941 |
| X-Ray structures |
|
   |
371 |
374 |
365 | 398 |
| NMR structures |
|
   |
300 |
301 |
296 | 311 | 31 |
| Total structures |
|
   |
640 |
650 |
623 | 709 |
[activity table created 2012-02-04]
NESG (PSI-Biology)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
3,200 |
6,436 |
2,297 |
| Expression tested |
|
   |
3,389 |
6,387 |
2,499 |
| Expressed (E > 0) |
|
   |
2,879 |
4,804 |
2,214 |
| Expressed-Soluble (S > 0) |
|
   |
2,062 |
2,981 |
1,725 |
| Expressed-Soluble (ES >= 9) |
|
   |
1,709 |
2,421 |
1,455 |
| Fermented |
|
   |
894 |
1,280 |
760 |
| Purified (>= 0.5 mg yield) |
|
   |
726 |
1,010 |
636 |
| HSQC spectra recorded |
|
   |
362 |
480 |
328 |
| "Good" HSQC spectra |
|
   |
200 |
253 |
188 |
| Crystal hit |
|
   |
128 |
146 |
126 |
| X-Ray structures |
|
   |
58 |
58 |
57 | 62 |
| NMR structures |
|
   |
64 |
64 |
63 | 64 | 4 |
| Total structures |
|
   |
118 |
119 |
116 | 126 |
[activity table created 2012-02-04]
Human proteins
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
4,988 |
9,698 |
3,426 |
| Expression tested |
|
   |
4,592 |
8,533 |
3,177 |
| Expressed (E > 0) |
|
   |
3,574 |
6,038 |
2,567 |
| Expressed-Soluble (S > 0) |
|
   |
2,389 |
3,590 |
1,861 |
| Expressed-Soluble (ES >= 9) |
|
   |
1,891 |
2,754 |
1,505 |
| Fermented |
|
   |
1,026 |
1,461 |
788 |
| Purified (>= 0.5 mg yield) |
|
   |
727 |
1,047 |
562 |
| HSQC spectra recorded |
|
   |
373 |
515 |
303 |
| "Good" HSQC spectra |
|
   |
202 |
264 |
173 |
| Crystal hit |
|
   |
128 |
148 |
108 |
| X-Ray structures |
|
   |
34 |
34 |
33 | 36 |
| NMR structures |
|
   |
62 |
62 |
59 | 63 | 8 |
| Total structures |
|
   |
88 |
90 |
83 | 99 |
[attrition table created 2012-02-04]
Eukaryotic proteins
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
6,069 |
12,095 |
4,393 |
| Expression tested |
|
   |
5,387 |
10,111 |
3,875 |
| Expressed (E > 0) |
|
   |
4,079 |
6,876 |
3,009 |
| Expressed-Soluble (S > 0) |
|
   |
2,728 |
4,099 |
2,175 |
| Expressed-Soluble (ES >= 9) |
|
   |
2,129 |
3,118 |
1,728 |
| Fermented |
|
   |
1,496 |
2,261 |
1,249 |
| Purified (>= 0.5 mg yield) |
|
   |
797 |
1,153 |
628 |
| HSQC spectra recorded |
|
   |
561 |
861 |
488 |
| "Good" HSQC spectra |
|
   |
265 |
374 |
234 |
| Crystal hit |
|
   |
135 |
155 |
115 |
| X-Ray structures |
|
   |
40 |
40 |
39 | 45 |
| NMR structures |
|
   |
85 |
85 |
82 | 87 | 8 |
| Total structures |
|
   |
117 |
119 |
112 | 132 |
[attrition table created 2012-02-04]
Prokaryotic proteins
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
16,970 |
22,862 |
13,040 |
| Expression tested |
|
   |
16,206 |
21,515 |
12,372 |
| Expressed (E > 0) |
|
   |
12,301 |
15,238 |
9,841 |
| Expressed-Soluble (S > 0) |
|
   |
9,428 |
11,278 |
8,029 |
| Expressed-Soluble (ES >= 9) |
|
   |
7,582 |
8,982 |
6,517 |
| Fermented |
|
   |
5,565 |
6,670 |
4,984 |
| Purified (>= 0.5 mg yield) |
|
   |
3,869 |
4,427 |
3,454 |
| HSQC spectra recorded |
|
   |
1,932 |
2,329 |
1,745 |
| "Good" HSQC spectra |
|
   |
1,040 |
1,275 |
952 |
| Crystal hit |
|
   |
1,144 |
1,271 |
1,063 |
| X-Ray structures |
|
   |
493 |
496 |
485 | 525 |
| NMR structures |
|
   |
353 |
355 |
350 | 371 | 33 |
| Total structures |
|
   |
813 |
824 |
796 | 896 |
[attrition table created 2012-02-04]
CRSH
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
82 |
142 |
82 |
| Expression tested |
|
   |
81 |
140 |
81 |
| Expressed (E > 0) |
|
   |
67 |
104 |
67 |
| Expressed-Soluble (S > 0) |
|
   |
59 |
89 |
59 |
| Expressed-Soluble (ES >= 9) |
|
   |
50 |
76 |
50 |
| Fermented |
|
   |
20 |
28 |
20 |
| Purified (>= 0.5 mg yield) |
|
   |
19 |
26 |
19 |
| HSQC spectra recorded |
|
   |
13 |
20 |
13 |
| "Good" HSQC spectra |
|
   |
8 |
12 |
8 |
| Crystal hit |
|
   |
2 |
3 |
2 |
| X-Ray structures |
|
   |
1 |
1 |
1 | 1 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
1 |
1 |
1 | 1 |
[attrition table created 2012-02-04]
PSI-2 BIG domains assigned to NESG
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
0 |
0 |
0 |
| Expression tested |
|
   |
0 |
0 |
0 |
| Expressed (E > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (S > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (ES >= 9) |
|
   |
0 |
0 |
0 |
| Fermented |
|
   |
0 |
0 |
0 |
| Purified (>= 0.5 mg yield) |
|
   |
0 |
0 |
0 |
| HSQC spectra recorded |
|
   |
0 |
0 |
0 |
| "Good" HSQC spectra |
|
   |
0 |
0 |
0 |
| Crystal hit |
|
   |
0 |
0 |
0 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
0 |
0 |
0 | 0 |
[attrition table created 2012-02-04]
PSI-2 BIG domains
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
0 |
0 |
0 |
| Expression tested |
|
   |
0 |
0 |
0 |
| Expressed (E > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (S > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (ES >= 9) |
|
   |
0 |
0 |
0 |
| Fermented |
|
   |
0 |
0 |
0 |
| Purified (>= 0.5 mg yield) |
|
   |
0 |
0 |
0 |
| HSQC spectra recorded |
|
   |
0 |
0 |
0 |
| "Good" HSQC spectra |
|
   |
0 |
0 |
0 |
| Crystal hit |
|
   |
0 |
0 |
0 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
0 |
0 |
0 | 0 |
[attrition table created 2012-02-04]
Ubiquitin-like domains
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
5 |
5 |
5 |
| Expression tested |
|
   |
5 |
5 |
5 |
| Expressed (E > 0) |
|
   |
4 |
4 |
4 |
| Expressed-Soluble (S > 0) |
|
   |
2 |
2 |
2 |
| Expressed-Soluble (ES >= 9) |
|
   |
2 |
2 |
2 |
| Fermented |
|
   |
4 |
4 |
4 |
| Purified (>= 0.5 mg yield) |
|
   |
1 |
1 |
1 |
| HSQC spectra recorded |
|
   |
1 |
1 |
1 |
| "Good" HSQC spectra |
|
   |
1 |
1 |
1 |
| Crystal hit |
|
   |
0 |
0 |
0 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
3 |
3 |
3 | 3 |
| Total structures |
|
   |
3 |
3 |
3 | 3 |
[attrition table created 2012-02-04]
Human Ubiquitin-like domains
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
0 |
0 |
0 |
| Expression tested |
|
   |
0 |
0 |
0 |
| Expressed (E > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (S > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (ES >= 9) |
|
   |
0 |
0 |
0 |
| Fermented |
|
   |
0 |
0 |
0 |
| Purified (>= 0.5 mg yield) |
|
   |
0 |
0 |
0 |
| HSQC spectra recorded |
|
   |
0 |
0 |
0 |
| "Good" HSQC spectra |
|
   |
0 |
0 |
0 |
| Crystal hit |
|
   |
0 |
0 |
0 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
0 |
0 |
0 | 0 |
[attrition table created 2012-02-04]
PSI-Biology community outreach
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
396 |
695 |
320 |
| Expression tested |
|
   |
381 |
659 |
316 |
| Expressed (E > 0) |
|
   |
323 |
521 |
270 |
| Expressed-Soluble (S > 0) |
|
   |
276 |
424 |
243 |
| Expressed-Soluble (ES >= 9) |
|
   |
247 |
355 |
222 |
| Fermented |
|
   |
248 |
334 |
231 |
| Purified (>= 0.5 mg yield) |
|
   |
211 |
278 |
197 |
| HSQC spectra recorded |
|
   |
87 |
102 |
80 |
| "Good" HSQC spectra |
|
   |
51 |
62 |
47 |
| Crystal hit |
|
   |
88 |
97 |
86 |
| X-Ray structures |
|
   |
36 |
36 |
35 | 39 |
| NMR structures |
|
   |
22 |
22 |
22 | 22 | 2 |
| Total structures |
|
   |
56 |
57 |
55 | 61 |
[attrition table created 2012-02-04]
D. Baker outreach targets
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
118 |
132 |
117 |
| Expression tested |
|
   |
115 |
128 |
115 |
| Expressed (E > 0) |
|
   |
99 |
109 |
99 |
| Expressed-Soluble (S > 0) |
|
   |
94 |
103 |
94 |
| Expressed-Soluble (ES >= 9) |
|
   |
91 |
100 |
91 |
| Fermented |
|
   |
99 |
107 |
99 |
| Purified (>= 0.5 mg yield) |
|
   |
86 |
93 |
86 |
| HSQC spectra recorded |
|
   |
35 |
35 |
35 |
| "Good" HSQC spectra |
|
   |
18 |
18 |
18 |
| Crystal hit |
|
   |
36 |
36 |
36 |
| X-Ray structures |
|
   |
11 |
11 |
11 | 12 |
| NMR structures |
|
   |
7 |
7 |
7 | 7 |
| Total structures |
|
   |
18 |
18 |
18 | 19 |
[attrition table created 2012-02-04]
HCPIN (Human Cancer Interaction Networks)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
| cloned |
|
   |
2,462 |
6,032 |
1,240 |
| Expression tested |
|
   |
2,202 |
5,091 |
1,107 |
| Expressed (E > 0) |
|
   |
1,783 |
3,609 |
998 |
| Expressed-Soluble (S > 0) |
|
   |
1,209 |
2,146 |
774 |
| Expressed-Soluble (ES >= 9) |
|
   |
965 |
1,648 |
642 |
| Fermented |
|
   |
620 |
973 |
416 |
| Purified (>= 0.5 mg yield) |
|
   |
476 |
734 |
335 |
| HSQC spectra recorded |
|
   |
284 |
411 |
221 |
| "Good" HSQC spectra |
|
   |
165 |
219 |
137 |
| Crystal hit |
|
   |
108 |
126 |
88 |
| X-Ray structures |
|
   |
24 |
24 |
23 | 26 |
| NMR structures |
|
   |
47 |
47 |
45 | 48 | 6 |
| Total structures |
|
   |
65 |
67 |
61 | 74 |
[attrition table created 2012-02-04]
Mitochondrial Proteome Partnership
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
384 |
948 |
189 |
| Expression tested |
|
   |
381 |
941 |
187 |
| Expressed (E > 0) |
|
   |
294 |
648 |
156 |
| Expressed-Soluble (S > 0) |
|
   |
144 |
256 |
93 |
| Expressed-Soluble (ES >= 9) |
|
   |
109 |
191 |
72 |
| Fermented |
|
   |
65 |
112 |
52 |
| Purified (>= 0.5 mg yield) |
|
   |
52 |
86 |
41 |
| HSQC spectra recorded |
|
   |
21 |
38 |
18 |
| "Good" HSQC spectra |
|
   |
10 |
16 |
9 |
| Crystal hit |
|
   |
8 |
9 |
8 |
| X-Ray structures |
|
   |
1 |
1 |
1 | 1 |
| NMR structures |
|
   |
2 |
2 |
2 | 2 |
| Total structures |
|
   |
3 |
3 |
3 | 3 |
[attrition table created 2012-02-04]
Mitochondrial Proteome Partnership - nominated targets
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
171 |
450 |
76 |
| Expression tested |
|
   |
168 |
443 |
74 |
| Expressed (E > 0) |
|
   |
147 |
356 |
71 |
| Expressed-Soluble (S > 0) |
|
   |
81 |
158 |
49 |
| Expressed-Soluble (ES >= 9) |
|
   |
55 |
106 |
35 |
| Fermented |
|
   |
29 |
62 |
22 |
| Purified (>= 0.5 mg yield) |
|
   |
20 |
41 |
15 |
| HSQC spectra recorded |
|
   |
9 |
22 |
7 |
| "Good" HSQC spectra |
|
   |
6 |
12 |
5 |
| Crystal hit |
|
   |
2 |
3 |
2 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
1 |
1 |
1 | 1 |
| Total structures |
|
   |
1 |
1 |
1 | 1 |
[attrition table created 2012-02-04]
Chaperone-Enabled Studies of Epigenetic Regulation Enzymes
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
179 |
464 |
107 |
| Expression tested |
|
   |
172 |
442 |
101 |
| Expressed (E > 0) |
|
   |
153 |
368 |
93 |
| Expressed-Soluble (S > 0) |
|
   |
91 |
155 |
69 |
| Expressed-Soluble (ES >= 9) |
|
   |
76 |
118 |
61 |
| Fermented |
|
   |
41 |
62 |
36 |
| Purified (>= 0.5 mg yield) |
|
   |
31 |
42 |
29 |
| HSQC spectra recorded |
|
   |
7 |
11 |
6 |
| "Good" HSQC spectra |
|
   |
7 |
11 |
6 |
| Crystal hit |
|
   |
3 |
3 |
3 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
2 |
2 |
2 | 2 |
| Total structures |
|
   |
2 |
2 |
2 | 2 |
[attrition table created 2012-02-04]
Human transcription factors
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | HUGO ids |
|
| cloned |
|
   |
1,714 |
2,756 |
1,377 | 1,372 |
| Expressed (E > 0) |
|
   |
1,469 |
2,146 |
1,214 | 1,211 |
| Expressed-Soluble (S > 0) |
|
   |
1,123 |
1,530 |
953 | 952 |
| Expressed-Soluble (ES >= 9) |
|
   |
904 |
1,214 |
779 | 779 |
| Purified (>= 0.5 mg yield) |
|
   |
166 |
252 |
127 | 130 |
[attrition table created 2012-02-04]
Bet v1-like super family
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
0 |
0 |
0 |
| Expression tested |
|
   |
0 |
0 |
0 |
| Expressed (E > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (S > 0) |
|
   |
0 |
0 |
0 |
| Expressed-Soluble (ES >= 9) |
|
   |
0 |
0 |
0 |
| Fermented |
|
   |
0 |
0 |
0 |
| Purified (>= 0.5 mg yield) |
|
   |
0 |
0 |
0 |
| HSQC spectra recorded |
|
   |
0 |
0 |
0 |
| "Good" HSQC spectra |
|
   |
0 |
0 |
0 |
| Crystal hit |
|
   |
0 |
0 |
0 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
0 |
0 |
0 | 0 |
[attrition table created 2012-02-04]
Philips Enzyme Natural Products project (closed)
| Production stage |
|
 |
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
| cloned |
|
   |
28 |
71 |
26 |
| Expression tested |
|
   |
28 |
71 |
26 |
| Expressed (E > 0) |
|
   |
26 |
62 |
24 |
| Expressed-Soluble (S > 0) |
|
   |
15 |
29 |
13 |
| Expressed-Soluble (ES >= 9) |
|
   |
14 |
26 |
12 |
| Fermented |
|
   |
11 |
12 |
11 |
| Purified (>= 0.5 mg yield) |
|
   |
11 |
12 |
11 |
| HSQC spectra recorded |
|
   |
4 |
4 |
4 |
| "Good" HSQC spectra |
|
   |
3 |
3 |
3 |
| Crystal hit |
|
   |
3 |
3 |
3 |
| X-Ray structures |
|
   |
0 |
0 |
0 | 0 |
| NMR structures |
|
   |
0 |
0 |
0 | 0 |
| Total structures |
|
   |
0 |
0 |
0 | 0 |
[attrition table created 2012-02-04]
|